Brain Cancer Drugs Market Research Reports

From
Ependymoma - Pipeline Review, H2 2018 - Product Thumbnail Image

Ependymoma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 188 Pages
From
Oligodendroglioma - Pipeline Review, H2 2018 - Product Thumbnail Image

Oligodendroglioma - Pipeline Review, H2 2018

  • Drug Pipelines
  • 155 Pages
From
From
From
From
From
From
From
From
Loading Indicator

With low survival rates primary brain cancers such as glioblastoma multiforme (the most common and aggressive of malignant brain tumours) are among the deadliest forms of cancer. Drug development activity is therefore intense in this sector, with resulting business development opportunities. Reports in the Brain Cancer section enable you to explore various facets of the industry from a variety of expert viewpoints, including R&D (clinical trials, drug discovery, etc.), competitive landscape, supply and demand, regional markets, regional market analysis, and much more. Show Less Read more

adroll